The role of glia in the physiology and pharmacology of glucagon‐like peptide‐1: implications for obesity, diabetes, neurodegeneration and glaucoma
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The medical applications of glucagon‐like peptide‐1 receptor (GLP‐1R) agonists is evergrowing in scope, highlighting the urgent need for a comprehensive understanding of the mechanisms through which GLP‐1R activation impacts physiology and behaviour. A new area of research aims to elucidate the role GLP‐1R signalling in glia, which play a role in regulating energy balance, glycemic control, neuroinflammation and oxidative stress. Once controversial, existing evidence now suggests that subsets of glia (e.g. microglia, tanycytes and astrocytes) and infiltrating macrophages express GLP‐1Rs. In this review, we discuss the implications of these findings, with particular focus on the effectiveness of both clinically available and novel GLP‐1R agonists for treating metabolic and neurodegenerative diseases, enhancing cognition and combating substance abuse. LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetoc
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968 · cited 1×
“…of the CNS and are unique among macrophages in that they self-renew from their original yolk sac line- age in adulthood (Ajami et al., 2007; Bruttger et al., 2015; Elmore et al., 2014; Epelman et al., 2014; Ginhoux et al., 2010; Hoeffel et al., 2015; Mildner et al., 2007; Sheng et al., 2015).”
BackgroundEpelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494 · cited 2×
“Peripheral macrophages, in contrast, derive not only from the primordial yolk sac (Alliot et al., 1999; Ginhoux & Merad, 2011) but also from foetal mono- cytes and haematopoietic stem cells (Epelman et al., 2014; Hoeffel et al., 2015; Sheng et al., 2015).”
BackgroundAn environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
Hoeffel, G., Chen, J., Lavin, Y., Low, D., Almeida, F. F., See, P., Beaudin, A. E., Lum, J., Low, I., Forsberg, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.011 · Cited by 1,135
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 3×
“…that a subset of glia, including a heterogeneous group of astrocytes, express GLP-1Rs and/or are responsive to GLP-1 phar- macology (C. H. Lee et al., 2018; Gong et al., 2014; Reiner et al., 2016; Sterling et al., 2020b; Yun et al., 2018), along with the idea that glia may facilitate…”
BackgroundMicroglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · cited 2×
“to injury, disease and microglia depletion, peripheral macrophages demonstrate morphology and expression profiles similar to resident microglia (Ajami et al., 2011; Bennett et al., 2018; Varvel et al., 2012).”
BackgroundThe arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896
Athauda, D., Maclagan, K., Skene, S. S., Bajwa-Joseph, M., Letchford, D., Chowdhury, K., Hibbert, S., Budnik, N., Zampedri, L., Dickson, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31585-4 · Cited by 889 · cited 1×
“exenatide improved both motor and nonmotor deficits in patients with Parkinson's disease (Athauda et al., 2017) and liraglutide improved amyloid β accumulation (Gejl et al.”
BackgroundMicroglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain
Alliot, F., Godin, I., & Pessac, B. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00113-3 · Cited by 884 · cited 2×
“Peripheral macrophages, in contrast, derive not only from the primordial yolk sac (Alliot et al., 1999; Ginhoux & Merad, 2011) but also from foetal mono- cytes and haematopoietic stem cells (Epelman et al., 2014; Hoeffel et al., 2015; Sheng et al., 2015).”
BackgroundSemaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717
McClean, P. L., Parthsarathy, V., Faivre, E., & Hölscher, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-11.2011 · Cited by 698
Bruttger, J., Karram, K., Wörtge, S., Regen, T., Marini, F., Hoppmann, N., Klein, M., Blank, T., Yona, S., Wolf, Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.012 · Cited by 634 · cited 1×
“…of the CNS and are unique among macrophages in that they self-renew from their original yolk sac line- age in adulthood (Ajami et al., 2007; Bruttger et al., 2015; Elmore et al., 2014; Epelman et al., 2014; Ginhoux et al., 2010; Hoeffel et al., 2015; Mildner et al., 2007; Sheng et al.,…”
BackgroundLi, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · cited 3×
“…effects (Li et al., 2009; McClean et al., 2011; Perry et al., 2002; Sterling et al., 2020b), while reducing β-amyloid plaque accumulation (Li et al., 2009; McClean et al., 2011; Perry et al., 2003), enhancing neuronal progenitor cell differentiation (Hamilton et al., 2011; McClean et…”
BackgroundAnti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530 · cited 1×
“In support of this possibility, GLP-1R agonists have been shown to modulate macrophage pheno- types and decrease macrophage infiltration in rodent models of diabetes (Y. S. Lee et al., 2012), atherosclerosis and nephropathy (Y. S. Lee & Jun, 2016), and multiple sclerosis (Chiou et al., 2019).”
BackgroundA combination of ontogeny and CNS environment establishes microglial identity
Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Hayden Gephart, M., Plowey, E. D., & Barres, B. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.014 · Cited by 524
Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00108 · Cited by 480
Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472 · cited 1×
“Indeed, in the initial creation of the GLP- 1R–Cre founder strains, Richards et al. (2014) reported that although one founder strain displayed expected GLP-1R expression, the other strain showed sparse expression in pancreatic islets.”
BackgroundAthauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · cited 1×
“GLP-1R activation initiates a signalling cascade that inhibits the release of pro-inflammatory cytokines and astrocyte transformation to a neurotoxic (A1) phenotype, both key contributors to the patho- genesis of Parkinson's and Alzheimer's neurodegeneration (Athauda & Foltynie, 2016).”
BackgroundProtection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380 · cited 1×
“GLP-1 receptor (GLP-1R) agonists have been shown to exert antiapoptotic and neuro- protective effects (Li et al., 2009; McClean et al., 2011; Perry et al., 2002; Sterling et al., 2020b), while reducing β-amyloid plaque accumulation (Li et al., 2009; McClean et al., 2011; Perry et al.,…”
BackgroundBertilsson, G., Patrone, C., Zachrisson, O., Andersson, A., Dannaeus, K., Heidrich, J., Kortesmaa, J., Mercer, A., Nielsen, E., Rönnholm, H., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21483 · Cited by 345
Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding
Kim, J. G., Suyama, S., Koch, M., Jin, S., Argente-Arizon, P., Argente, J., Liu, Z.-W., Zimmer, M. R., Jeong, J. K., Szigeti-Buck, K., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3725 · Cited by 336
Lee, Y.-S., Park, M.-S., Choung, J.-S., Kim, S.-S., Oh, H.-H., Choi, C.-S., Ha, S.-Y., Kang, Y., Kim, Y., & Jun, H.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2592-3 · Cited by 319 · cited 1×
“In support of this possibility, GLP-1R agonists have been shown to modulate macrophage pheno- types and decrease macrophage infiltration in rodent models of diabetes (Y. S. Lee et al., 2012), atherosclerosis and nephropathy (Y. S. Lee & Jun, 2016), and multiple sclerosis (Chiou et al., 2019).”
BackgroundImproved tools to study astrocytes
Yu, X., Nagai, J., & Khakh, B. S. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0264-8 · Cited by 298 · cited 2×
“Although historically the tools have been lacking for interrogating glia in vivo, multiple recent advancements are likely to be of interest to the GLP-1 research community and should be utilized (Yu et al., 2020).”
BackgroundMethodLanglet, F., Mullier, A., Bouret, S. G., Prevot, V., & Dehouck, B. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23355 · Cited by 295
GLP-1 and weight loss: unraveling the diverse neural circuitry
Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290 · cited 1×
“…of GLP-1R agonists to distributed CNS nuclei suppresses food intake and body weight, modulates reward, and/or produces behavioural measures of malaise (Kanoski et al., 2016), the contribution of glia in mediating GLP-1R agonist's action has not been investigated in the majority of these nuclei.”
BackgroundSelf-citationKim, S., Moon, M., & Park, S. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0132 · Cited by 263
Liu, W., Jalewa, J., Sharma, M., Li, G., Li, L., & Hölscher, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.054 · Cited by 246 · cited 1×
“…and lixisenatide, have been shown to prevent dopamine neuronal degeneration in multiple studies utilizing toxin-induced nigrostriatal degeneration, resulting in improved motor function (Bertilsson et al., 2008; Harkavyi et al., 2008; Li et al., 2009; Liu et al., 2015; S. Kim et al., 2009).”
BackgroundNeurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Guttenplan, K. A., Stafford, B. K., El-Danaf, R. N., Adler, D. I., Münch, A. E., Weigel, M. K., Huberman, A. D., & Liddelow, S. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107776 · Cited by 221 · cited 2×
“…elevation stimulates microglia/ macrophages (CD11b+ cells) to produce IL-1α, TNF-α and C1q, a trio of pro-inflammatory cytokines necessary and sufficient to induce A1 astrocyte transformation and retinal ganglia cell death (Guttenplan et al., 2020; Liddelow et al., 2017; Sterling et al., 2020a).”
BackgroundGlucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
Shiraishi, D., Fujiwara, Y., Komohara, Y., Mizuta, H., & Takeya, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.086 · Cited by 208
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., & Oka, J.-I. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.008 · Cited by 207
McClean, P. L., Gault, V. A., Harriott, P., & Hölscher, C. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.023 · Cited by 193
The central GLP-1: implications for food and drug reward
Skibicka, K. P. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00181 · Cited by 188 · cited 1×
“2022;179:715–726. wileyonlinelibrary.com/journal/bph © 2021 The British Pharmacological Society 715 et al., 2014; Hsu et al., 2015; Isacson et al., 2011; Shirazi, Dickson, & Skibicka, 2013; Skibicka, 2013; Sorensen et al., 2015; Wang et al., 2010).”
Adams, J. M., Pei, H., Sandoval, D. A., Seeley, R. J., Chang, R. B., Liberles, S. D., & Olson, D. P. (2018) · Diabetes · doi:10.2337/db17-1385 · Cited by 159 · cited 1×
“Indeed, even within the NTS, recent reports have clearly indicated that glutamatergic (Adams et al., 2018) and GABAergic (Fortin et al., 2020) neurons expressing GLP-1Rs are both needed to observe full intake suppression following GLP-1 ligand delivery.”
BackgroundSterling, J. K., Adetunji, M. O., Guttha, S., Bargoud, A. R., Uyhazi, K. E., Ross, A. G., Dunaief, J. L., & Cui, Q. N. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108271 · Cited by 148
Self-citationAgulhon, C., Boyt, K. M., Xie, A. X., Friocourt, F., Roth, B. L., & McCarthy, K. D. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.261289 · Cited by 147
Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance
Reiner, D. J., Mietlicki-Baase, E. G., McGrath, L. E., Zimmer, D. J., Bence, K. K., Sousa, G. L., Konanur, V. R., Krawczyk, J., Burk, D. H., Kanoski, S. E., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3579-15.2016 · Cited by 133 · cited 10×
“Not only are axons of GLP-1 producing preproglucagon (PPG) neurons in close apposition with NTS astrocytes, approximately one third of NTS astrocytes respond to GLP-1R agonists by intracellular calcium signal- ling (Reiner et al., 2016).”
BackgroundInfluentialSelf-citationFortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127 · cited 2×
“Indeed, even within the NTS, recent reports have clearly indicated that glutamatergic (Adams et al., 2018) and GABAergic (Fortin et al., 2020) neurons expressing GLP-1Rs are both needed to observe full intake suppression following GLP-1 ligand delivery.”
BackgroundSelf-citationWang, X. H., Li, L., Hölscher, C., Pan, Y. F., Chen, X. R., & Qi, J. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.028 · Cited by 99 · cited 2×
“2022;179:715–726. wileyonlinelibrary.com/journal/bph © 2021 The British Pharmacological Society 715 et al., 2014; Hsu et al., 2015; Isacson et al., 2011; Shirazi, Dickson, & Skibicka, 2013; Skibicka, 2013; Sorensen et al., 2015; Wang et al., 2010).”
BackgroundGlucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma
Sterling, J., Hua, P., Dunaief, J. L., Cui, Q. N., & VanderBeek, B. L. (2023) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-319232 · Cited by 75
Self-citation
Research works printed but not linked: 91
- 10.1038/nn2014 · DOI · Paper page
- 10.1111/bph.14747 · DOI · Paper page
- 10.1146/annurev.physiol.63.1.795 · DOI · Paper page
- 10.1139/y99-076 · doi:10.1139/y99-076 · Paper page
- 10.1016/j.cmet.2012.10.003 · DOI · Paper page
- 10.1002/cpim.70 · DOI · Paper page
- 10.1523/JNEUROSCI.22-01-00183.2002 · DOI · Paper page
- 10.3390/ijms20071584 · DOI · Paper page
- 10.1054/npep.1999.0757 · DOI
- 10.1074/jbc.M209454200 · DOI · Paper page
- 10.3791/57122 · DOI
- 10.1016/j.molmet.2015.07.008 · DOI · Paper page
- 10.1016/S0301-0082(00)00067-8 · DOI · Paper page
- 10.1016/j.physbeh.2012.03.014 · DOI · Paper page
- 10.1016/j.exer.2014.05.004 · DOI
- Fan Y., 2014, Exendin‐4 protects retinal cells from early diabetes in Goto‐Kakizaki rats by increasing the Bcl‐2/Bax and Bcl‐xL/Bax ratios and reducing reactive gliosis, Molecular Vision, 20, 1557
- 10.1186/s13063-019-3259-x · DOI · Paper page
- 10.1016/j.cmet.2012.09.005 · DOI
- 10.1172/JCI64102 · DOI · Paper page
- 10.1210/en.2010-1252 · DOI · Paper page
- 10.1016/j.neurobiolaging.2010.02.014 · DOI · Paper page
- 10.1126/science.1194637 · DOI · Paper page
- 10.1051/medsci/2011278013 · DOI
- 10.1523/JNEUROSCI.4703-13.2014 · DOI · Paper page
- 10.1038/mp.2012.141 · DOI · Paper page
- 10.1038/ijo.2009.10 · DOI · Paper page
- 10.3389/fnins.2017.00308 · DOI
- 10.1146/annurev-physiol-021909-135843 · DOI · Paper page
- 10.1002/jnr.22565 · DOI · Paper page
- 10.1016/j.neurobiolaging.2012.04.009 · DOI
- 10.1186/1742-2094-5-19 · DOI · Paper page
- 10.1016/j.physbeh.2012.02.017 · DOI · Paper page
- 10.1016/j.physbeh.2010.02.029 · DOI · Paper page
- 10.1016/j.cmet.2011.02.001 · DOI · Paper page
- 10.1146/annurev-nutr-071812-161201 · DOI · Paper page
- 10.1016/j.cmet.2009.10.009 · DOI · Paper page
- 10.1177/1073858407305725 · DOI · Paper page
- 10.1016/j.brainres.2009.03.059 · DOI
- 10.1038/s41386-018-0010-3 · DOI · Paper page
- 10.1038/npp.2014.175 · DOI · Paper page
- 10.1038/mp.2017.91 · DOI · Paper page
- 10.1210/en.2007-0633 · DOI · Paper page
- 10.1210/en.2006-1572 · DOI · Paper page
- 10.1016/j.ejphar.2010.10.008 · DOI
- Kawasaki A., 2000, Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity, Investigative Ophthalmology & Visual Science, 41, 3444
- 10.1016/j.brainres.2013.01.012 · DOI
- 10.1210/en.2004-0419 · DOI · Paper page
- 10.1167/iovs.02-0255 · DOI · Paper page
- 10.1007/s12035-017-0550-2 · DOI
- 10.3233/JAD-2010-1314 · DOI · Paper page
- 10.1038/s41366-020-00658-5 · DOI
- 10.1016/j.neulet.2004.11.016 · DOI
- 10.1002/glia.23774 · DOI · Paper page
- 10.1002/glia.23283 · DOI · Paper page
- 10.1172/JCI26309 · DOI · Paper page
- 10.3389/fnins.2013.00249 · DOI
- 10.1016/j.autneu.2012.12.006 · DOI
- 10.1016/j.brainres.2012.07.029 · DOI
- 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19990111)403:2<261::aid-cne8>3.0.co;2-5
- 10.1016/0361-9230(92)90068-9 · DOI
- 10.1038/oby.2006.318 · DOI · Paper page
- 10.1073/pnas.97.9.4926 · DOI · Paper page
- 10.1038/sj.ijo.0802265 · DOI
- 10.1038/369744a0 · DOI · Paper page
- 10.1046/j.1471-4159.2000.0751076.x · DOI · Paper page
- 10.1152/ajpendo.00464.2009 · DOI · Paper page
- 10.1002/jnr.10611 · DOI · Paper page
- 10.1111/j.1463-1326.2010.01259.x · DOI · Paper page
- 10.18632/aging.100557 · DOI
- 10.1080/02713683.2020.1737137 · DOI
- 10.1126/science.6264602 · DOI · Paper page
- 10.1016/j.physbeh.2006.05.036 · DOI
- 10.1152/ajpendo.00367.2013 · DOI · Paper page
- 10.1016/j.immuni.2015.07.016 · DOI · Paper page
- 10.1073/pnas.1306799110 · DOI · Paper page
- 10.1371/journal.pone.0061965 · DOI · Paper page
- 10.2337/db16-1364 · DOI · Paper page
- 10.1016/j.tig.2017.12.008 · DOI · Paper page
- 10.1016/j.physbeh.2015.06.013 · DOI · Paper page
- 10.1152/ajpendo.00025.2012 · DOI · Paper page
- 10.1016/j.ejcb.2017.03.004 · DOI
- 10.1038/s41398-020-0767-0 · DOI
- 10.1101/2020.06.18.146720 · doi:10.1101/2020.06.18.146720
- 10.1101/2021.01.16.21249949 · DOI
- 10.1002/ana.10519 · DOI · Paper page
- 10.1167/iovs.02-1136 · DOI · Paper page
- 10.1210/en.2007-1166 · DOI · Paper page
- 10.1073/pnas.1210150109 · DOI · Paper page
- 10.1016/s0304-3940(98)00813-1 · DOI
- 10.3390/brainsci8080143 · DOI
- 10.1155/2019/9605265 · DOI · Paper page
Cited by
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 302
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Diz-Chaves, Y., Mastoor, Z., Spuch, C., González-Matías, L. C., & Mallo, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179583 · Cited by 148
“The primary source of endogenous GLP-1 within the brain is a population of preproglucagon (PPG) neurons in the caudal portion of the nucleus of the solitary tract (NTS).”
BackgroundInfluentialNiazi, S., Gnesin, F., Thein, A.-S., Andreasen, J. R., Horwitz, A., Mouhammad, Z. A., Jawad, B. N., Niazi, Z., Pourhadi, N., Zareini, B., et al. (2024) · Ophthalmology · doi:10.1016/j.ophtha.2024.03.004 · Cited by 47
Muayad, J., Loya, A., Hussain, Z. S., Chauhan, M. Z., Alsoudi, A. F., De Francesco, T., & Ahmed, I. I. K. (2025) · Ophthalmology · doi:10.1016/j.ophtha.2024.08.023 · Cited by 45
Metadata
- Authors
- Cui, Q. N., Stein, L. M., Fortin, S. M., & Hayes, M. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2021-11-23
- Volume
- 179
- Issue
- 4
- Pages
- 715-726
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W3199696254
- Cited by
- 71
- References
- 43
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institutes of Health (NIH‐DK115762, NIH‐EY029765)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.